1. Home
  2. CYTK vs DY Comparison

CYTK vs DY Comparison

Compare CYTK & DY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYTK
  • DY
  • Stock Information
  • Founded
  • CYTK 1997
  • DY 1969
  • Country
  • CYTK United States
  • DY United States
  • Employees
  • CYTK N/A
  • DY N/A
  • Industry
  • CYTK Biotechnology: Pharmaceutical Preparations
  • DY Water Sewer Pipeline Comm & Power Line Construction
  • Sector
  • CYTK Health Care
  • DY Industrials
  • Exchange
  • CYTK Nasdaq
  • DY Nasdaq
  • Market Cap
  • CYTK 5.6B
  • DY 5.3B
  • IPO Year
  • CYTK 2004
  • DY N/A
  • Fundamental
  • Price
  • CYTK $32.00
  • DY $235.28
  • Analyst Decision
  • CYTK Buy
  • DY Strong Buy
  • Analyst Count
  • CYTK 15
  • DY 10
  • Target Price
  • CYTK $73.71
  • DY $233.10
  • AVG Volume (30 Days)
  • CYTK 2.0M
  • DY 449.1K
  • Earning Date
  • CYTK 05-06-2025
  • DY 05-21-2025
  • Dividend Yield
  • CYTK N/A
  • DY N/A
  • EPS Growth
  • CYTK N/A
  • DY 1.66
  • EPS
  • CYTK N/A
  • DY 7.89
  • Revenue
  • CYTK $19,218,000.00
  • DY $4,818,199,000.00
  • Revenue This Year
  • CYTK $24.01
  • DY $17.78
  • Revenue Next Year
  • CYTK $698.33
  • DY $7.78
  • P/E Ratio
  • CYTK N/A
  • DY $29.83
  • Revenue Growth
  • CYTK 412.21
  • DY 12.77
  • 52 Week Low
  • CYTK $29.31
  • DY $131.37
  • 52 Week High
  • CYTK $61.38
  • DY $235.29
  • Technical
  • Relative Strength Index (RSI)
  • CYTK 44.20
  • DY 86.37
  • Support Level
  • CYTK $30.02
  • DY $225.79
  • Resistance Level
  • CYTK $31.27
  • DY $230.57
  • Average True Range (ATR)
  • CYTK 1.32
  • DY 6.19
  • MACD
  • CYTK 0.38
  • DY 1.67
  • Stochastic Oscillator
  • CYTK 72.12
  • DY 99.29

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About DY Dycom Industries Inc.

Dycom Industries Inc is a provider of specialty contracting services to the telecommunications infrastructure and utility industries throughout the United States. Its operating companies supply telecommunications providers with a comprehensive portfolio of specialty services, including program management; planning; engineering and design; aerial, underground, and wireless construction; maintenance; and fulfillment services and provide underground facility locating services for various utilities, including telecommunications providers, and others. It also provides a range of construction, maintenance, and installation services, including the placement and splicing of fiber, copper, and coaxial cables. It provides services throughout the United States.

Share on Social Networks: